Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | Bornkamp, Björn, Zaoli, Silvia, Azzarito, Michela, Martin, Ruvie, Müller, Carsten Philipp, Moloney, Conor, Capestro, Giulia, Ohlssen, David, Baillie, Mark |
|---|---|
| Format: | Preprint |
| Publié: |
2023
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
par: Björn Bornkamp, et autres
Publié: (2024)
par: Björn Bornkamp, et autres
Publié: (2024)
Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
par: Bornkamp, Björn, et autres
Publié: (2026)
par: Bornkamp, Björn, et autres
Publié: (2026)
The Framework That Survives Bad Models: Human-AI Collaboration For Clinical Trials
par: Chen, Yao, et autres
Publié: (2025)
par: Chen, Yao, et autres
Publié: (2025)
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
par: Sechidis, Konstantinos, et autres
Publié: (2024)
par: Sechidis, Konstantinos, et autres
Publié: (2024)
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
par: Konstantinos Sechidis, et autres
Publié: (2024)
par: Konstantinos Sechidis, et autres
Publié: (2024)
Oggi la città
par: Capestro, Antonio
Publié: (2022)
par: Capestro, Antonio
Publié: (2022)
Progettando città
par: Capestro, Antonio
Publié: (2022)
par: Capestro, Antonio
Publié: (2022)
Patrimônio, Cidade e o Papel do Desenho Urbano
par: Antonio Capestro
Publié: (2021)
par: Antonio Capestro
Publié: (2021)
All that Glitters Is not Gold: Type‐I Error Controlled Variable Selection from Clinical Trial Data
par: Manuela R. Zimmermann, et autres
Publié: (2024)
par: Manuela R. Zimmermann, et autres
Publié: (2024)
Data-driven controlled subgroup selection in clinical trials
par: Müller, Manuel M., et autres
Publié: (2025)
par: Müller, Manuel M., et autres
Publié: (2025)
Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
par: Ballerini, Veronica, et autres
Publié: (2023)
par: Ballerini, Veronica, et autres
Publié: (2023)
Comparing methods to assess treatment effect heterogeneity in general parametric regression models
par: Chen, Yao, et autres
Publié: (2025)
par: Chen, Yao, et autres
Publié: (2025)
Randomization-based Inference for MCP-Mod
par: Pin, Lukas, et autres
Publié: (2024)
par: Pin, Lukas, et autres
Publié: (2024)
Futility analyses for the MCP-Mod methodology based on longitudinal models
par: Bornkamp, Björn, et autres
Publié: (2024)
par: Bornkamp, Björn, et autres
Publié: (2024)
Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models
par: Björn Bornkamp, et autres
Publié: (2025)
par: Björn Bornkamp, et autres
Publié: (2025)
Impact of an educational intervention utilising a three‐dimensional‐printed model for ultrasound‐guided intra‐articular injections of the dislocated shoulder
par: Conor Cosgrave, et autres
Publié: (2024)
par: Conor Cosgrave, et autres
Publié: (2024)
Osteoblastic metastasis secondary to mammary carcinoma in a dog ( Canis lupus familiaris ) presenting with lameness
par: David Sheehan, et autres
Publié: (2025)
par: David Sheehan, et autres
Publié: (2025)
The opportunities and challenges to introduce pharmaceutical care in Cuba
par: Martínez Sánchez, Alina de las Mercedes
Publié: (2023)
par: Martínez Sánchez, Alina de las Mercedes
Publié: (2023)
OSI: Will It Ever See the Light of Day?
par: Moloney, Peter
Publié: (1997)
par: Moloney, Peter
Publié: (1997)
Delivering medicines in a challenging environment: the pharmaceutical sector in East Timor (a descriptive study)
par: Pauline Norris
Publié: (2007)
par: Pauline Norris
Publié: (2007)
Fun With Fourier Series
par: Baillie, Robert
Publié: (2008)
par: Baillie, Robert
Publié: (2008)
Symmetry and Self-Bound Droplets in Dipolar Molecular Gases
par: Baillie, D.
Publié: (2025)
par: Baillie, D.
Publié: (2025)
Summing the curious series of Kempner and Irwin
par: Baillie, Robert
Publié: (2008)
par: Baillie, Robert
Publié: (2008)
‘Action Needed’—The Critical Role of Peer Reviewers for Evidence‐Based Kidney Care
par: Jessica Baillie
Publié: (2026)
par: Jessica Baillie
Publié: (2026)
How stronger patent protection in India might affect the behavior of trasnational pharmaceutical industries / Carsten Fink
par: Fink, Carsten
Publié: (2000)
par: Fink, Carsten
Publié: (2000)
Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
par: Sechidis, Konstantinos, et autres
Publié: (2025)
par: Sechidis, Konstantinos, et autres
Publié: (2025)
Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation
par: Veronica Ballerini, et autres
Publié: (2025)
par: Veronica Ballerini, et autres
Publié: (2025)
Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
par: Konstantinos Sechidis, et autres
Publié: (2025)
par: Konstantinos Sechidis, et autres
Publié: (2025)
Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
par: Yao Chen, et autres
Publié: (2026)
par: Yao Chen, et autres
Publié: (2026)
Always a Manager? Assessing the Commission's Capacity to Manage and Deepen the Post‐Brexit EU–UK Relationship Whilst Expanding Its Competencies
par: David Moloney, et autres
Publié: (2025)
par: David Moloney, et autres
Publié: (2025)
Normal subgroups and permutation characters: a correction to a proof of Klingen
par: Muller, Peter, et autres
Publié: (2025)
par: Muller, Peter, et autres
Publié: (2025)
Response to “Comment on Development of a Novel Frailty Trigger for Use at Triage in the Emergency Department”
par: Elizabeth Moloney, et autres
Publié: (2025)
par: Elizabeth Moloney, et autres
Publié: (2025)
Removal of pharmaceuticals during drinking water treatment
Publié: (2002)
Publié: (2002)
Gender, Migration and Categorisation
par: Moloney, Deirdre M.
Publié: (2025)
par: Moloney, Deirdre M.
Publié: (2025)
Emotion Regulation in Procedural Medicine: From Suppression to Integration
par: Brian M. Moloney
Publié: (2025)
par: Brian M. Moloney
Publié: (2025)
Functional-Integral Based Perturbation Theory for the Malthus-Verhulst Process
par: Nicholas R. Moloney
Publié: (2006)
par: Nicholas R. Moloney
Publié: (2006)
Profinite groups with complemented closed subgroups
par: Fernández-Alcober, Gustavo A., et autres
Publié: (2025)
par: Fernández-Alcober, Gustavo A., et autres
Publié: (2025)
Motivations and challenges for M-Business Transformation: a multiple-case study
par: Heng-Sheng Tsai
Publié: (2007)
par: Heng-Sheng Tsai
Publié: (2007)
On the challenge of simulating dipolar contributions to spin relaxation with generalized cluster correlation expansion methods
par: Ryan, Conor, et autres
Publié: (2026)
par: Ryan, Conor, et autres
Publié: (2026)
Origin of Phobos and Deimos : Orbital evolution shortly after formation from a potential dislocation
par: Dahoumane, Ryan, et autres
Publié: (2025)
par: Dahoumane, Ryan, et autres
Publié: (2025)
Documents similaires
-
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
par: Björn Bornkamp, et autres
Publié: (2024) -
Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
par: Bornkamp, Björn, et autres
Publié: (2026) -
The Framework That Survives Bad Models: Human-AI Collaboration For Clinical Trials
par: Chen, Yao, et autres
Publié: (2025) -
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
par: Sechidis, Konstantinos, et autres
Publié: (2024) -
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
par: Konstantinos Sechidis, et autres
Publié: (2024)